Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.

Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...

Young Minuteman Press franchise owner, Caroline Sweeney, has brought fresh energy and new potential to her Ashland based ...

Robert F. Kennedy Jr., Trump’s pick for health secretary, sought to use Samoa’s measles vaccine pause as a "natural ...